Inception Return
(10/2/2007)
|
9.56 %
|
|
YTD Return
|
-4.87 %
|
|
NAVPS
(11/19/2024)
|
$15.35
|
|
Change
|
($0.06) / -0.39 %
|
|
|
Growth of $10,000
(As of October 31, 2024)
|
|
MER
|
1.77 %
|
|
Assets ($mil)
|
-
|
|
Rank (1Yr)
|
257/265
|
|
Std Dev (3Yr)
|
14.27 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The objective of the Mawer Global Small Cap Fund is to provide above-average long-term, risk-adjusted returns by investing primarily in securities of smaller companies around the world. The Fund will be primarily invested in equities and equity-related securities. The amount invested in any one country will vary depending upon the economic, investment, and market outlook and opportunities in each area.
|
Fund Manager
Mawer Investment Management Ltd.
Portfolio Manager
Christian Deckart, Mawer Investment Management Ltd.
Karan Phadke, Mawer Investment Management Ltd.
John Wilson, Mawer Investment Management Ltd.
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of September 30, 2024)
|
Sector Allocation
(As of September 30, 2024)
|
Geographic Allocation
(As of September 30, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Ipsos SA | International Equity | Consumer Services | European Union | 5.52% |
| Hikma Pharmaceuticals PLC | International Equity | Healthcare | European Union | 4.83% |
| De' Longhi SpA | International Equity | Consumer Goods | European Union | 4.76% |
| Donnelley Financial Solutions Inc | US Equity | Industrial Services | United States | 4.76% |
| Alten SA | International Equity | Technology | European Union | 4.49% |
| Gps Participacoes e Empreendimentos SA | International Equity | Industrial Services | Latin America | 4.06% |
| Orkla ASA | International Equity | Consumer Goods | Other European | 3.82% |
| Electrocomponents PLC | International Equity | Technology | European Union | 3.58% |
| Fagron NV | International Equity | Healthcare | European Union | 3.55% |
| Dermapharm Holding SE | International Equity | Healthcare | European Union | 3.50% |
Performance Data
(As of October 31, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-6.13
|
-7.51
|
-3.99
|
-4.87
|
5.57
|
-4.49
|
2.77
|
7.56
|
|
Benchmark
|
0.86
|
2.61
|
10.28
|
14.94
|
30.02
|
5.07
|
9.11
|
9.28
|
|
Quartile Ranking
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
2
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
13.92
|
-17.73
|
4.82
|
14.74
|
24.39
|
-2.56
|
20.81
|
-0.68
|
29.14
|
12.06
|
|
Benchmark
|
14.59
|
-13.14
|
15.50
|
11.07
|
20.09
|
-7.34
|
15.40
|
7.47
|
16.61
|
9.59
|
|
Quartile Ranking
|
2
|
3
|
4
|
3
|
1
|
1
|
1
|
4
|
1
|
2
|